Effectiveness of the Assessment of Burden of COPD (ABC) tool on health-related quality of life in patients with COPD: A cluster randomised controlled trial in primary and hospital care

BMJ Open

Volumn 6, Issue 7, 2016, Pages

  Slok, Annerika H M ^a   Kotz, Daniel ^a,b   Van Breukelen, Gerard ^a   Chavannes, Niels H ^c   Rutten Van Mölken, Maureen P M H ^d   Kerstjens, Huib A M ^e   Van Der Molen, Thys ^e   Asijee, Guus M ^a,f   Dekhuijzen, P N Richard ^g   Holverda, Sebastiaan ^h   Salomé, Philippe L ⁱ   Goossens, Lucas M A ^d   Twellaar, Mascha ^a   In't Veen, Johannes C C M ^j   Van Schayck, Onno C P ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f PICASSO for COPD   (Netherlands)

^g RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^h Lung Foundation Netherlands   (Netherlands)

ⁱ Huisartsencoöperatie PreventZorg   (Netherlands)

^j SZT Centre of Excellence for Asthma and COPD   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALGORITHM; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; CONTROLLED STUDY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HOSPITAL; HOSPITAL CARE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRIMARY MEDICAL CARE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCIENTIST; SCORING SYSTEM; ST. GEORGE RESPIRATORY QUESTIONNAIRE; AGED; COST OF ILLNESS; HEALTH STATUS; HOSPITALIZATION; MIDDLE AGED; NETHERLANDS; PATIENT SATISFACTION; PRIMARY HEALTH CARE; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX;

AGED; COST OF ILLNESS; FEMALE; HEALTH STATUS; HOSPITALIZATION; HOSPITALS; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PATIENT SATISFACTION; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF HEALTH CARE; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES;

EID: 85016276477     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2016-011519     Document Type: Article

References (65)

1. Mannino DM, Homa DM, Akinbami LJ, et al. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWR Surveill Summ 2002;51:1-16.
2. Feenstra TL, van Genugten ML, Hoogenveen RT, et al. The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands. Am J Respir Crit Care Med 2001;164:590-6.
3. From the Global Strategy for Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2014. Secondary From the Global Strategy for Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2014. http://www.goldcopd.org/
4. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-46.
5. Gruffydd-Jones K. A national strategy for the management of chronic obstructive pulmonary disease (COPD) in England: aiming to improve the quality of care for patients. Prim Care Respir J 2008;17 (Suppl 1):S1-8.
6. Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157: 1418-22.
7. Miravitlles M, Ferrer M, Pont A, et al. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax 2004;59:387-95.
8. Miravitlles M, Molina J, Naberan K, et al. Factors determining the quality of life of patients with COPD in primary care. Ther Adv Respir Dis 2007;1:85-92.
9. Slok AHM, In 't Veen JCCM, Chavannes NH, et al. Development of the Assessment of Burden of COPD tool: an integrated tool to measure the burden of COPD. NPJ Prim Care Respir Med 2014;24: 14021.
10. van der Molen T, Willemse BW, Schokker S, et al. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes 2003;1:13.
11. Slok AHM, Bemelmans TCH, Kotz D, et al. The Assessment of Burden of COPD (ABC) scale: a reliable and valid questionnaire. COPD 2016 [epub ahead of print].
12. Bourbeau J, Nault D, Dang-Tan T. Self-management and behaviour modification in COPD. Patient Educ Couns 2004;52:271-7.
13. Hill K, Vogiatzis I, Burtin C. The importance of components of pulmonary rehabilitation, other than exercise training, in COPD. Eur Respir Rev 2013;22:405-13.
14. Jones PW. St. George's Respiratory Questionnaire: MCID. Copd 2005;2:75-9.
15. Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD Assessment Test. Eur Respir J 2009;34:648-54.
16. Glasgow RE, Wagner EH, Schaefer J, et al. Development and validation of the Patient Assessment of Chronic Illness Care (PACIC). Med Care 2005;43:436-44.
17. Slok AHM,-In 't Veen JCCM, Chavannes NH, et al. Effectiveness of the Assessment of Burden of Chronic Obstructive Pulmonary Disease (ABC) tool: study protocol of a cluster randomised trial in primary and secondary care. BMC Pulm Med 2014;14:131.
18. Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54:581-6.
19. Long Alliantie Nederland. Zorgstandaard COPD. Amersfoort: Long Alliantie Nederland, 2010.
20. Smeele IJM, Van Weel C, Van Schayck CP, et al. NHG-Standaard COPD [Dutch national guideline COPD in primary care]. Huisarts Wet 2007;50:362-79.
21. Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med 1991;85(Suppl B):25-31; discussion 33-7.
22. Jones PW, Quirk FH, Baveystock CM, et al. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992;145:1321-7.
23. Jones PW, Forde Y. St George's respiratory questionnaire manual. 2.3 ed. London: St. George's University of London, 2009.
24. Smidth M, Olesen F, Fenger-Grøn M, et al. Patient-experienced effect of an active implementation of a disease management programme for COPD-a randomised trial. BMC Fam Pract 2013;14:147.
25. Laird NM, Wang F. Estimating rates of change in randomized clinical trials. Control Clin Trials 1990;11:405-19.
26. Liu GF, Lu K, Mogg R, et al. Should baseline be a covariate or dependent variable in analyses of change from baseline in clinical trials? Stat Med 2009;28:2509-30.
27. van Breukelen GJ. ANCOVA Versus CHANGE From Baseline in Nonrandomized Studies: the difference. Multivariate Behav Res 2013;48:895-922.
28. Hedeker D. A mixed-effects multinomial logistic regression model. Stat Med 2003;22:1433-46.
29. Gupta N, Pinto LM, Morogan A, et al. The COPD assessment test: a systematic review. Eur Respir J 2014;44:873-84.
30. Tsiligianni IG, van der Molen T, Moraitaki D, et al. Assessing health status in COPD. A head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ). BMC Pulm Med 2012;12:20.
31. Sarioglu N, Hismiogullari AA, Bilen C, et al. Is the COPD assessment test (CAT) effective in demonstrating the systemic inflammation and other components in COPD? Rev Port Pneumol (2006) 2016;22:11-17.
32. Siler TM, Kerwin E, Singletary K, et al. Efficacy and Safety of Umeclidinium Added to Fluticasone Propionate/Salmeterol in Patients with COPD: results of Two Randomized, Double-Blind Studies. Copd 2016;13:1-10.
33. Mendoza L, Horta P, Espinoza J, et al. Pedometers to enhance physical activity in COPD: a randomised controlled trial. Eur Respir J 2015;45:347-54.
34. Ghobadi H, Lari SM, Pourfarzi F, et al. The effects of atorvastatin on mustard-gas-exposed patients with chronic obstructive pulmonary disease: A randomized controlled trial. J Res Med Sci 2014;19:99-105.
35. Dodd JW, Hogg L, Nolan J, et al. The COPD assessment test (CAT): response to pulmonary rehabilitation. A multicentre, prospective study. Thorax 2011;66:425-9.
36. Jones PW, Harding G, Wiklund I, et al. Tests of the responsiveness of the COPD assessment test following acute exacerbation and pulmonary rehabilitation. Chest 2012;142:134-40.
37. Dodd JW, Marns PL, Clark AL, et al. The COPD Assessment Test (CAT): short- and medium-term response to pulmonary rehabilitation. Copd 2012;9:390-4.
38. Kon SS, Clark AL, Dilaver D, et al. Response of the COPD Assessment Test to pulmonary rehabilitation in unselected chronic respiratory disease. Respirology 2013;18:974-7.
39. Joosten EA, DeFuentes-Merillas L, de Weert GH, et al. Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status. Psychother Psychosom 2008;77:219-26.
40. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, Part 2. JAMA 2002;288:1909-14.
41. Cicutto L, Brooks D, Henderson K. Self-care issues from the perspective of individuals with chronic obstructive pulmonary disease. Patient Educ Couns 2004;55:168-76.
42. Agusti A, Macnee W. The COPD control panel: towards personalised medicine in COPD. Thorax 2013;68:687-90.
43. Peters JB, Daudey L, Heijdra YF, et al. Development of a battery of instruments for detailed measurement of health status in patients with COPD in routine care: the Nijmegen Clinical Screening Instrument. Qual Life Res 2009;18:901-12.
44. Coultas D, Frederick J, Barnett B, et al. A randomized trial of two types of nurse-assisted home care for patients with COPD. Chest 2005;128:2017-24.
45. Oga T, Tsukino M, Hajiro T, et al. Analysis of longitudinal changes in dyspnea of patients with chronic obstructive pulmonary disease: an observational study. Respir Res 2012;13:85.
46. van Wetering CR, Hoogendoorn M, Mol SJ, et al. Short- and long-term efficacy of a community-based COPD management programme in less advanced COPD: a randomised controlled trial. Thorax 2010;65:7-13.
47. Boxall AM, Barclay L, Sayers A, et al. Managing chronic obstructive pulmonary disease in the community. A randomized controlled trial of home-based pulmonary rehabilitation for elderly housebound patients. J Cardiopulm Rehabil 2005;25:378-85.
48. Chavannes NH, Grijsen M, van den Akker M, et al. Integrated disease management improves one-year quality of life in primary care COPD patients: a controlled clinical trial. Prim Care Respir J 2009;18:171-6.
49. Koff PB, Jones RH, Cashman JM, et al. Proactive integrated care improves quality of life in patients with COPD. Eur Respir J 2009;33:1031-8.
50. Bourbeau J, Julien M, Maltais F, et al, Chronic Obstructive Pulmonary Disease axis of the Respiratory Network Fonds de la Recherche en Santé du Québec. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med 2003;163:585-91.
51. Monninkhof E, van der Valk P, van der Palen J, et al. Effects of a comprehensive self-management programme in patients with chronic obstructive pulmonary disease. Eur Respir J 2003;22:815-20.
52. Kruis AL, Boland MR, Assendelft WJ, et al. Effectiveness of integrated disease management for primary care chronic obstructive pulmonary disease patients: results of cluster randomised trial. BMJ 2014;349:g5392.
53. Zwerink M, Brusse-Keizer M, van der Valk PD, et al. Self management for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2014;(3):CD002990.
54. Hermiz O, Comino E, Marks G, et al. Randomised controlled trial of home based care of patients with chronic obstructive pulmonary disease. BMJ 2002;325:938.
55. Kruis AL, Smidt N, Assendelft WJ, et al. Integrated disease management interventions for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2013;(10): CD009437.
56. Oliver SM. Living with failing lungs: the doctor-patient relationship. Fam Pract 2001;18:430-9.
57. Makoul G, Clayman ML. An integrative model of shared decision making in medical encounters. Patient Educ Couns 2006;60:301-12.
58. Elwyn G, Frosch D, Thomson R, et al. Shared decision making: a model for clinical practice. J Gen Intern Med 2012;27:1361-7.
59. Lemmens KM, Nieboer AP, Huijsman R. A systematic review of integrated use of disease-management interventions in asthma and COPD. Respir Med 2009;103:670-91.
60. Tashkin D, Kesten S. Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses. Chest 2003;123:1441-9.
61. Casaburi R, Mahler DA, Jones PW, et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 2002;19:217-24.
62. Rutten-van Mölken M, Roos B, Van Noord JA. An empirical comparison of the St George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical trial setting. Thorax 1999;54:995-1003.
63. Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008;359:1543-54.
64. Spencer S, Calverley PM, Sherwood Burge P, et al. Health status deterioration in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:122-8.
65. Jones PW, Bosh TK. Quality of life changes in COPD patients treated with salmeterol. Am J Respir Crit Care Med 1997;155:1283-9.